A Phase 1 Study of SSGJ-709 in Patients With Advanced Malignant Tumors

Clinical trial NCT07016490 · RECRUITING

Trial details

NCT number: NCT07016490
Sponsor: Shenyang Sunshine Pharmaceutical Co., LTD.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Malignant Tumors

Start date: 2025-06-12
Primary completion: 2027-09-30
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.